Revvity Jun 8, 2026 How Investors May Respond To Revvity (RVTY) Divesting Its China Immunodiagnostics Business - simplywall.st
Revvity Jun 5, 2026 A Look At Revvity (RVTY) Valuation After Recent Share Price Momentum And Margin Expansion Narrative - simplywall.st
Revvity Jun 1, 2026 Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - TradingView
Revvity May 31, 2026 Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - StockStory
Revvity May 20, 2026 Revvity Inc. stock (US76155R1086): investors weigh latest earnings and diagnostics focus - AD HOC NEWS
Revvity May 19, 2026 Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - Sahm
Revvity May 18, 2026 Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - simplywall.st
Revvity May 14, 2026 Revvity secures FDA clearance for total testosterone immunoassay - Medical Device Network
Revvity May 14, 2026 Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution - BioSpace
Revvity May 13, 2026 FDA Clears Revvity Total Testosterone Assay for Automated Testing - Clinical Lab Products
Revvity May 13, 2026 Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution - Yahoo Finance
Revvity May 12, 2026 Revvity stock (US76155R1086): Q1 earnings beat and analyst upgrade drive gains - AD HOC NEWS
Revvity May 11, 2026 Revvity stock (US76155R1086): Q1 earnings beat and analyst upgrade drive gains - AD HOC NEWS